Is Lucid Diagnostics Inc (LUCD) overvalued? · rev $4.3M
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
This page asks whether Lucid Diagnostics Inc (LUCD) looks expensive on cached numbers — not a short thesis.
Latest reported LUCD revenue for 2024-12-31 was $4.3M. Net income was -$45.5M. Revenue was up 79.0% from 2023-12-31 to 2024-12-31. LUCD currently screens at market cap $123.3M.
LUCD currently screens at market cap $123.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LUCD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LUCD stock page for the full model, not this heading.
Not investment advice.